Stay updated on Menin Inhibitor Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.

Latest updates to the Menin Inhibitor Combo in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe displayed site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected content, preventing access to the study details. This appears to be a site-access issue rather than an update to the study information.SummaryDifference18%

- Check46 days agoChange DetectedThe contact information heading capitalization was standardized, and the site revision label was updated from v3.6.6 to v3.7.0, reflecting a newer build.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision label in the page footer updated to v3.6.6 (replacing v3.6.5). This signals a site version update without changes to the study information.SummaryDifference0.1%

- Check67 days agoChange DetectedThe changes reflect updates to the page's revision history with new and prior update dates, indicating administrative updates rather than alterations to the study details.SummaryDifference0.2%

Stay in the know with updates to Menin Inhibitor Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.